Heartflow

HTFL · NASDAQ

$55.59+$4.57 (+8.96%)TodayMarket closed ·
Prev close $51.02

About HTFL

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The company is headquartered in Mountain View, California and currently employs 843 full-time employees. The company went IPO on 2025-08-08. The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Employees
843
Headquarters
Mountain View, California
Listed
Aug 8, 2025
Sector
Health Care
Industry
Health Care Technology

HTFL key statistics

Market cap
4.83B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.60M
Volume
3.03M
Open price
$51.92
High today
$56.30
Low today
$51.00
52 Week high
$54.32
52 Week low
$20.13

Heartflow (HTFL) at a glance

As of Oct 20, 2026, Heartflow (HTFL) shares are priced at $55.59, giving the company a market cap of 4.83B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $51.00 and $56.30. The current price is 9.0% above the day's low and 1.3% below its high.

Volume so far is 3.03M shares, above the average of 1.60M shares a day.

Over the past year Heartflow has ranged from $20.13 to $54.32, and now sits 104% of the way up that range.

Heartflow met or beat analyst EPS estimates in 2 of the last 5 quarters. In Q2 FY26 it reported -$0.07 per share against an estimate of -$0.1364.

The average analyst price target is $47.05, 15.4% below the current price, from 10 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

80%of 10 analyst ratings say Buy
  • Buy80.0%
  • Hold20.0%
  • Sell0.0%
Price target · 11 analystsAvg $47.05
Low
$39.39
Now
$55.59
High
$58.80

HTFL earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 5 quarters, by 39.5% on average.

  1. Q2 FY25: reported -$3.15 per share against an estimate of -$0.4964
  2. Q3 FY25: reported -$0.35 per share against an estimate of -$0.2244
  3. Q4 FY25: reported -$0.12 per share against an estimate of -$0.1722
  4. Q1 FY26: reported -$0.23 per share against an estimate of -$0.1915
  5. Q2 FY26: reported -$0.07 per share against an estimate of -$0.1364

HTFL news

  • 10 Health Care Stocks With Whale Alerts In Today’s Session

  • Henry Khederian

    HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releasePRNewswire

    16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap

  • Press releaseGlobe Newswire

    A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech

  • Press releaseGlobe Newswire

    The Future of Intoxication Detection May Be in Your Voice

Similar companies

Companies in the same industry as Heartflow

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.